Under the agreement, Healthscreen will provide a range of important clinical measurements to Sanofi-aventis to offer assistance in research activities.

Healthscreen said the partnership will assist the company in expanding its Chronic Condition Management (CCM) offering.

Heathscreen president and CEO Justin Belobaba said they are very excited to partner with Sanofi-aventis as they continue to enhance their CCM offering which focuses on assisting diabetic patients in managing their condition.

"Healthscreen’s CCM service will assist patients in managing their care, improving their health and therefore their quality of life," Belobaba said.